Tag: PCI

ESC 2021: One month DAPT is “becoming standard of care” for high bleeding risk patients following PCI

 Marco Valgimigli (Lugano, Switzerland) talks to Cardiovascular News about the latest findin...

Roxana Mehran on managing ischaemic benefit vs. bleeding harm in HBR patients (A three-part series)

Please NOTE: This video is ONLY available to watch in selected countries and geographiesJTVCZ2VvaXAt...
Woman patient

Black patients have higher rates of death after PCI

Black patients who undergo percutaneous coronary intervention (PCI) are at an increased risk for m...

Miracor Medical’s PiCSO System receives CE mark

Miracor Medical has announced the award of the CE mark for its latest generation of PiCSO Impuls...

Abiomed initiates online education platform for PCI

Abiomed has launched a virtual physician education programme, CAMP PCI (Coronary artery and myoc...

Keith Oldroyd to become CMO at Biosensors

Biosensors International Group has announced the appointment of Keith G Oldroyd to the post of c...

CeloNova completes enrolment in first 14-day DAPT randomised controlled trial

CeloNova BioSciences has announced that it has successfully completed enrolment into the COBRA RED...

Paclitaxel coated balloons have lower risk of mortality in coronary arteries at three years than control treatments

Paclitaxel drug coated balloons (DCB) for percutaneous treatment of coronary artery disease (CAD...
Philips iFR Coregistration SyncVision

Philips announces DEFINE GPS study of PCI guided by integrated iFR and X-ray

Philips has announced a new randomised controlled trial to assess percutaneous coronary interven...

EXCEL finds repeat revascularisations following both CABG and PCI lead to increased mortality

A secondary analysis of repeat revascularisation in the EXCEL trial has found that it was associ...
Corresponding author Evald Hoj Christiansen

NOBLE finds PCI inferior to CABG at five years in left main disease

Five-year data from the NOBLE trial have confirmed its earlier findings that in patients with un...

Further innovation and research is required for thrombus aspiration in PCI

The TASTE and TOTAL studies suggested that routine thombus aspiration in patients undergoing per...

AHA 2019: ISCHEMIA shows no benefit for revascularisation in patients with stable ischaemic heart disease

The largest trial to date to compare revascularisation with a conservative strategy in patients ...

AHA 2019: Preprocedural COLCHICINE-PCI finds a lowering of inflammation, but no reduction in myocardial injury

Preprocedural administration of an oral colchicine load does not reduce the risk of myocardial i...

Corindus completes first transcontinental simulated telerobotic PCI procedures over 5G, fibre, and public internet networks

Corindus has announced the completion of the first multicity, transcontinental percutaneous coro...

GLOBAL LEADERS: no sex-difference in mortality or MI rates two years after PCI, but bleeding risk higher in women than men

A prespecified subgroup analysis of the GLOBAL LEADERS trial has found no between-sex difference...

US FDA grants Breakthrough Device designation to CorFlow Infusion System

CorFlow Therapeutics has announced that the company has been granted Breakthrough Device designa...

Two further studies support three-month DAPT following PCI

Further evidence for a shorter duration of dual antiplatelet therapy (DAPT) in patients implante...

Patients with angiographically-intermediate coronary lesions

Using optical coherence tomography (OCT)-to guide percutaneous coronary intervention (PCI) is as...

Penumbra announces enrolment of first patient in study of mechanical power aspiration for thrombus removal in coronary vessels

Penumbra has announced the enrolment of the first patient into the CHEETAH study, a prospective,...

TCT 2019: Apixaban plus a P2Y12 inhibitor is the optimal strategy for AF with ACS and/or PCI

A prespecified analysis of data from the AUGUSTUS study, released at late-breaking session at th...

TCT 2019: Resolute Onyx noninferior to BioFreedom in high bleeding risk patients treated with one-month DAPT

ONYX ONE, the first randomised trial to compare a durable polymer drug-eluting stent to a polyme...

TCT 2019: Benefits of complete revascularisation continue to accumulate over the long term

A timing substudy of the COMPLETE trial has found that, compared with culprit-lesion only percut...
complete-revascularisation

ESC 2019: Complete revascularisation superior to culprit lesion-only PCI in STEMI and multivessel CAD irrespective of timing of intervention

A strategy of complete revascularisation was superior to culprit lesion-only percutaneous corona...

The influence of technology and robotics in the catheterisation laboratory is growing

Thanks to the use of robotics in healthcare, many procedures that were once highly invasive are ...

Cordis expands its interventional cardiology portfolio with full US launch of radial products

Cordis, a Cardinal Health company, has announced the full US launch of its Radial 360 portfolio, off...

ACC 2019: Less bleeding with one-month DAPT than standard therapy, with no increased ischaemia

One-month dual antiplatelet therapy (DAPT) followed by 12 months of clopidogrel monotherapy leads to...

In some cases, we are not doing PCI in the right patients

 “The real question is: who should get percutaneous coronary intervention (PCI)? I do not believe ...

Evidence of substance abuse found in 10% of young myocardial infarction patients

Data from the YOUNG-MI registry indicate that 10% of young myocardial infarction patients (≤50 y...

TCT 2017: No advantage with extending dual antiplatelet therapy beyond six months in STEMI patients

The primary results from the DAPT-STEMI trial suggest that 12-month dual antiplatelet therapy (D...

Direct stenting with drug-eluting stents may be associated with better outcomes

Marco A Magalhaes (Department of Internal Medicine, MedStar Washington Hospital Center, Washingt...

ESC 2017: CABG is the “preferred strategy” for multivessel revascularisation in patients with type 1 diabetes

Data from a nationwide observational cohort study indicate that coronary artery bypass grafting (CAB...

Good care means ensuring patients are thoroughly informed

In 2010, Harlan M Krumholz wrote a commentary in the Journal of the American Medical Association...

ESC 2017: Hexacath’s titanium-nitride-oxide coated stent matches Boston Scientific’s Synergy for acute coronary syndrome

During a late-breaking science session at the European Society of Cardiology (ESC) congress (26–...

ESC 2017: Significantly lower event rates with Orsiro than with Xience

  Results from the BIOFLOW V study indicate that patients who undergo percutaneous coron...

ESC 2017: Case builds for dropping aspirin from triple therapy in atrial fibrillation patients post PCI

The RE-DUAL PCI trial indicates that dual therapy with the non-vitamin K antagonist oral anticoa...

Merit Medical partners with world-renown interventional cardiologist to deliver transradial course

Merit Medical will partner with internationally renowned interventional cardiologist Ferdinand Kieme...

Ruby anniversary: The key revolutions of the past 40 years

Advances in materials and techniques over the past 40 years have led to a substantial reduction ...

New study to evaluate safety of three-month DAPT with Xience in high bleeding risk patients

A new study, XIENCE Short DAPT, will evaluate whether three months of dual antiplatelet therapy ...

Roxwood Medical announces agreement with Abbott for distribution of products in USA

Roxwood Medical has entered into an exclusive agreement with Abbott for distribution of Roxwood ...

Black people do not have a higher rate of mortality one year after PCI

Taisei Kobayashi (Corporal Michael J Crescenz, Veterans Affairs Medical Center, Philadelphia, US...

Further data to support use of new-generation drug-eluting stents in women

A new study from the Women in Innovation Initiative and Drug-Eluting Stents (WIN-DES) collaborative ...

EuroPCR 2017: Switching to clopidogrel after one month reduces bleeding without increasing ischaemic events

Data from the TOPIC (Timing of platelet inhibition after acute coronary syndrome) study indicate...

Improving processes and outcome performance measures may be more be relevant than “arbitrary” PCI operator volume recommendations

Alexander C Fanaroff (Division of Cardiology, Duke University, Durham, USA) and others report in...

EuroPCR 2017: PCI outperforms medical management for treatment of chronic total occlusions

According to a study presented at EuroPCR (16–19 May, Paris, France), compared with optimal medi...

Survival benefit of early intervention in non-STEMI patients is independent of other factors

Sameer Arora (Division of Cardiology, University of North Carolina at Chapel Hill, Chapel Hill, ...

Dose-tracking system reduces radiation exposure to patients during PCI

A new study suggests that a novel skin dose-tracking system (Toshiba) may reduce radiation expos...

EuroPCR 2017: ABSORB China and ABSORB show both comparable safety and efficacy to Xience at three years.

Data presented from ABSORB China and ABSORB Japan at EuroPCR (16–19 May, Paris, France) show the...

SCAI 2017: New data from PLATINUM Diversity study provide further insight into under-served populations

New analyses from the PLATINUM Diversity study underscore the need for greater understanding of ...

The need to determine the relevance of stent malapposition

Despite a constant evolution in stent/scaffold design, stent failure is still perceived as a cli...

High HbA1c levels after coronary intervention may predict risk of adverse events

A new study indicates that patients with glycosylated haemoglobin A (HbA1c) ≥7 at two years after un...

“Simple five-item risk score” could be used to predict bleeding risk associated with dual antiplatelet therapy

Francesco Costa (Swiss Cardiovascular Center Bern, Bern University Hospital, Bern, Switzerland) ...

Study indicates that Impella heart pump reduces acute kidney injury during high-risk PCI

A new study published in Circulation Research finds that the use of haemodynamic support with Im...

American College of Cardiology update appropriate use criteria for performing coronary revascularisation in patients with stable disease

The American College of Cardiology (ACC), along with several partnering organisations, has relea...

Transradial PCI reduces costs

A new study published in JACC: Cardiovascular Interventions indicates that the transradial percutane...

PCI does not confer mortality benefit for diabetic patients with chronic total occlusions

Ki Hong Choi (Division of Cardiology, Department of Medicine, Cardiac and Vascular Centre, Samsu...

Physicians may be overlooking patients’ desire to avoid dual antiplatelet therapy drawbacks

A study, published in Catheterization and Cardiovascular Interventions, found that most patients...

“Telestenting” is possible with robotic PCI

Ryan D Madder (Frederik Meijer Heart & Vascular Institute, Spectrum Health, Grand Rapids, USA) a...

Performing PCI in comatose survivors of cardiac arrest

Because of a significant improvement in the prehospital treatment of patients with out-of-hospit...

Homemade pelvic drape significantly reduces radiation exposure to the operator during transradial coronary interventions

The RADIATION (Radiation dose in percutaneous coronary procedures through transradial approach u...

Perform PCI prior to TAVI in patients with both coronary artery disease and aortic stenosis

Stephen Ramee (Ochsner Medical Center, New Orleans, USA) and others outline in a paper in JACC: ...

Infection in the setting of STEMI

The association between infections and acute coronary syndromes has been the subject of interest...

AHA 2016: Heparin plus tirofiban is safe and effective for use during PCI

A new study, by researchers from the Intermountain Medical Center Heart Institute (Salt Lake Cit...

AHA 2016: Low-dose rivaroxaban reduces clinically significant bleeding in PCI patients with atrial fibrillation

Two drug regimens involving low doses of rivaroxaban (Xarelto, Bayer)—one with a 15mg once daily...

AHA 2016: Incomplete revascularisation after PCI increases risk of adverse events after surgery

Ehrin J Armstrong (Section of Cardiology, Denver VA Medical Center and University of Colorado Sc...

Patient enrolment complete in study assessing use of dabigatran atrial fibrillation patients undergoing PCI

  Patient enrolment into the international Phase IIIb RE-DUAL PCI study is complete. The...

TCT 2016: Three-year data fail to show Absorb to be superior or even non-inferior to Xience

According to the three-year results of the ABSORB II trial, a bioresorbable vascular scaffold (A...

TCT 2016: Women and minorities have a significantly higher risk of death after PCI than white men

Data from the PLATINUM DIVERSITY trial, which was presented at the 2016 Transcatheter Cardiovasc...

Adherence to medication more powerful predictor of adverse outcomes than type of revascularisation

A study published in Circulation has not only found that patients who adhere to medical regimens...

Experience matters when stenting the left main

According to a study published in JACC: Cardiovascular Interventions, patients undergoing left main ...

Mild-to-moderate chronic kidney disease no longer associated with worse outcomes after PCI

A new study indicates that patients with mild-to-moderate chronic kidney disease do not have wor...

Prophylactic ipsilateral ulnar compression significantly reduces risk of radial artery occlusion

Samir B Pancholy (The Wright Center for Graduate Medical Education, The Commonwealth Medical Col...

NORSTENT shows bare metal stents have improved

The NORSTENT (Norwegian coronary stent trial) study, which was presented at the 2016 European So...

Smartphones can help to streamline hospital transfer for myocardial infarction patients

A study published, as a research letter, in the Journal of the American College of Cardiology indica...

ESC 2016: Bare metal stents inferior to drug-eluting stents for saphenous vein graft PCI at three years

Data from a new study, BASKET-SAVAGE, indicate that patients who receive a drug-eluting stent wh...

ESC 2016: First head-to-head comparisons of prasugrel and ticagrelor shows no significant differences

The initial results of the first randomised controlled trial—PRAGUE 18—to directly compare prasu...

ESC 2016: Off-hours STEMI patients do not have worse outcomes

A new analysis of data from the CHAMPION PHOENIX (Cangrelor versus standard therapy to achieve o...

ESC 2016: Drug-eluting stents are still preferred despite no long-term survival advantage over bare metal stents

The results of NORSTENT (Norwegian coronary stent trial) indicate that second-generation drug-el...

Bolus version of Aggrastat is now approved in the USA

Medicure has received approval from the US Food and Drug Administration (FDA) for its new “bolus via...
Nicolas Meneveau

ESC 2016: Optical coherence tomography significantly improves functional outcomes after PCI

Nicolas Meneveau (Besancon, France) told delegates at the 2016 European Society of Cardiology (E...

ESC 2016: Short-term DAPT is feasible with Nobori biodegradable polymer stent

The NIPPON (Nobori dual antiplatelet therapy as appropriate duration) study, presented in a hotline ...

No advantage with beta-blockers post PCI for stable angina patients without prior myocardial infarction

Apurva Motivala (Division of Cardiology, Columbia University, New York, USA) and others report t...

Corindus Vascular Robotics and Acist collaborate to improve PCI workflow for physicians and patients

Corindus Vascular Robotics and Acist Medical Systems have come together to provide Fairview Sout...

Frequency of coronary perforation “might actually increase” given predictors include old age

Tim Kinnaird (Department of Cardiology, University Hospital of Wales, Cardiff, UK) and others re...

Essential Medical to start US trial of X-Seal 6F vascular closure device

Essential Medical has received investigational device exemption (IDE) approval from the FDA to begin...